FROM PAIN TO ACTIVE LIFE
- About actiTENS
A hope for pain sufferers!
actiTENS is a non-invasive, drug-free technology for relieving pain, reducing painkiller consumption¹, and improving the quality of life of patients suffering from chronic pain².
Discreet and versatile solution
actiTENS is a versatile solution that dynamically adapts to different body contours and pathologies. Its wide range of fastening accessories and electrodes — including multisite and low-back electrodes — provides a personalized and effective treatment experience for pain relief.
A Ready‑to‑Use Tablet Included
A tablet is included in the actiTENS kit, offering an optimized, ready‑to‑use experience. Preconfigured with the actiTENS app, it allows you to control your therapy sessions, access all programs, and track your treatment data—without requiring the use of any personal device.
Connected
actiTENS is controlled via a dedicated application on the included tablet, enabling patient account creation and personalized monitoring.
Ergonomic
actiTENS is engineered to adapt precisely to diverse anatomical areas and body contours, enhancing comfort and treatment efficacy³.
Discreet
actiTENS features a discreet design that enables patients to maintain their therapy program continuously, without disrupting daily activities.
- actiTENS application
Pain relief in your hands
With our interactive app, patients can wirelessly initiate treatment, record personalized therapy data, and monitor therapy outcomes.
Programs
Remote control
My health menu
Centralizes pain and stimulation data, with PDF export* and mobility monitoring via the integrated pedometer.
Patient account
Stores personal information, tracking data, and user preferences, all accessible through the app.
*This document in no way constitutes a diagnosis.
actiTENS in knee osteoarthritis (KOA) pain management
14 millions American citizens suffer from symptomatic KOA⁴.
62% of people with osteoarthritis treated in primary care had at least one comorbidity, the most common being: hypertension (37%), heart disease (8%) and diabetes (7%)⁵.
- actiTENS - Efficient device
A new wearable transcutaneous electrical nerve stimulation device (actiTENS) is more efficient and better tolerated than weak opioids in the treatment of knee osteoarthritis pain³
- KOA - CLINICAL STUDY
actiTENS has proven to be more effective than Level 2 analgesics³.
A clinical study conducted with 55 patients utilizing actiTENS for knee osteoarthritis pain management, compared to a second group of 55 patients consuming Level 2 analgesics for the same condition, revealed the following outcomes.
Pain reduction
actiTENS users experience a notably 2.06-point reduction in pain after 3 months surpassing results typically achieved with weak opioids.
Current activities
After 3 months of use, 84% of patients reported improved daily functioning based on responses collected through the Womac questionnaire.
actiTENS in endometriosis pain management
Endometriosis affects roughly 10% (190 million) of reproductive age women and girls globally⁶.
the most frequently reported symptoms of endometriosis are pelvic pain (92.5%), dyspareunia (80%) and heavy bleeding (75%)⁷.
Endometriosis has significant social, public health and economic implications. It can decrease quality of life due to severe pain, fatigue, depression, anxiety and infertility⁶.
- actiTENS is an option for the management of endometriosis-induced pain
actiTENS offers TENS and EMS mode stimulation programs designed to alleviate endometriosis pain, providing targeted relief.
- ENDOMETRIOSIS - SURVEY RESULTS
actiTENS may represent a relevant non‑pharmacological therapeutic option for managing pain associated with endometriosis.
An in‑app survey conducted among patients using actiTENS for endometriosis‑related pain management showed the following outcomes: reductions in pain levels, improvements in quality of life and activity limitations, and decreased medication use¹.
of patients using actiTENS reported an improvement in their pain.
of patients using actiTENS reported an improvement in their quality of life.
of patients, actiTENS results in an improvement in activity limitations.
of patients using actiTENS reported a reduction in drug consumption.
Control of actiTENS via a application enables us to carry out real-life surveys with patients to assess the device's effectiveness
- actiTENS vs competitors - SURVEY RESULTS
actiTENS vs competitors, from a patient's point of view
InApp survey conducted from 31/05 to 26/06/23 among 68 patients new users of actiTENS suffering from various pathologies and having previously used another TENS⁸.
of patients using actiTENS reported an improvement in their pain.
of patients using actiTENS consider it to be easier to use than other TENS already used.
actiTENS offers improved use of TENS therapy at work, outdoors and in daily activities for 82% of its users.
of patients report improved efficacy of actiTENS in reducing pain compared to other TENS used.
- Vision & Contact
Our mission is
To develop and offer sustainable, clinically-supported drug-free therapeutic solutions to improve quality of life and support pain sufferers worldwide.
Our location
137 rue mayoussard, 38430 Moirans FRANCE
Contact our support
Mobile : +1 (865) 748-8562 Phone : +33 (0) 4 76 37 17 58 E-mail : contactUS@sublimed-technologies.com
- Testimonial
What Our Patients Said
We have more than reviews on our store, join us in our commitment to a pain-free world !
Super device, I’m extremely satisfied with it, I use it every day for at least 3 hours, my neuropathic post-chemotherapy pain has halved. Thanks to this device, I’ve considerably reduced my consumption of painkillers. What’s more, the helpline is really top-notch, very responsive and guarantees user satisfaction. I couldn’t do without it, and I highly recommend it.
Patient 1
I’ve been using the actiTENS since September 2018. Almost 6 years of use without a single breakdown, which is rare reliability these days. It’s a real marvel and has quickly become indispensable. The application is easy to use, the equipment extremely efficient, and, above all, very discreet. With numerous programs and remarkable autonomy, I highly recommend it to people who need to return to work and want to continue their daily care routine.
Patient 2
Super device and super app, which allow me both to combat my chronic pain and to passively strengthen certain muscles. The equipment is top-quality and modern, and the device can be controlled via the app. Customer service is also top-notch. I’m very satisfied.
Patient 3
Very intuitive to use. actiTENS electrodes are highly effective and, unlike others, can be used for longer periods of time. Very light and discreet, for use anywhere. Well done! I recommend this treatment device.
Patient 4
Very intuitive to use. actiTENS electrodes are highly effective and, unlike others, can be used for longer periods of time. Very light and discreet, for use anywhere. Well donThis product is truly revolutionary, I don’t need to shoot up with painkillers anymore… The application is very easy to use and the after-sales service is very efficient. I highly recommend this product!
Patient 5
Sources
- The InApp survey conducted from 03/17 to 04/10/23 among 127 patients using actiTENS for the management of endometriosis pain showed that 61% of patients reported a reduction in medication consumption.
- The inApp survey conducted from 10/21 to 11/25/21 among 183 patients using actiTENS for the relief of various types of pain showed that 79% of patients noted an improvement in their quality of life.
- actiTENS, as a pain management solution, has undergone extensive clinical study (Etude Maheu – https://www.oarsijournal.com/article/S1063-4584(21)00599-9/fulltext). We remain committed to ongoing research to scientifically support its effectiveness in pain management.
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319385/
- https://www.medpagetoday.com/resource-centers/clinical-challenges-knee-osteoarthritis
- https://www.who.int/news-room/fact-sheets/detail/endometriosis
- https://pmc.ncbi.nlm.nih.gov/articles/PMC10241351/#:~:text=of%20women%20interviewed.-,Results,most%20commonly%20reported%20endometriosis%20symptoms.
- InApp survey conducted from 31/05 to 26/06/23 among 68 patients new users of actiTENS suffering from various pathologies and having previously used another TENS
actiTENS® has been cleared by the FDA (510(k): K202159) in December 2020. actiTENS® is a medical device subject to contraindications. Please carefully read the actiTENS® manual before use. RX only.
Download Our App
Explore an innovative approach to pain relief by downloading the actiTENS app now!
SAS Sublimed 813 959 012 00028- 137 rue Mayoussard 38430 Moirans – France – RCS Grenoble – Ref : SBM1AM021_US_V3 – Feb 2026
© Copyright – All rights reserved.